IPO registrations (S-1, F-1) · Registrants
OS Therapies Inc
- SEC CIK
- 1795091 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2023-03-31, last 2025-08-04; 6 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2024-08-01; declared effective 2024-02-14; withdrawal requested 2024-05-30
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 15825 SHADY GROVE ROAD, SUITE 135, Rockville, MD 20850
- EIN
- 82-5118368
- Ticker
- OSTX (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- OS Therapies Inc on the corporate pages
On this site
- Form D issuer: OS Therapies Inc EXACT (CIK (EXACT))
- SEC filer: OS Therapies Inc EXACT (CIK (EXACT))
Filings 28
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2023-03-31 | S-1 | S-1 (registration) | OS Therapies Inc | 0001213900-23-025493 ↗ |
| 2023-04-13 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-23-029526 ↗ |
| 2023-04-24 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-23-031796 ↗ |
| 2023-05-22 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-23-041699 ↗ |
| 2023-12-22 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-23-098158 ↗ |
| 2024-01-25 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-24-006228 ↗ |
| 2024-02-14 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-24-000446 ↗ |
| 2024-05-30 | RW | RW (withdrawal request) | OS Therapies Inc | 0001213900-24-048005 ↗ |
| 2024-05-30 | S-1 | S-1 (registration) | OS Therapies Inc | 0001213900-24-048049 ↗ |
| 2024-06-03 | RW | RW (withdrawal request) | OS Therapies Inc | 0001213900-24-048861 ↗ |
| 2024-06-03 | RW | RW (withdrawal request) | OS Therapies Inc | 0001213900-24-048904 ↗ |
| 2024-06-07 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-24-050739 ↗ |
| 2024-06-13 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-24-052373 ↗ |
| 2024-07-31 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-24-002332 ↗ |
| 2024-08-01 | 424B4 | 424B4 (final prospectus) | OS Therapies Inc | 0001213900-24-064156 ↗ |
| 2024-11-12 | S-1 | S-1 (registration) | OS Therapies Inc | 0001213900-24-096912 ↗ |
| 2024-11-27 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-24-103456 ↗ |
| 2025-01-03 | S-1/A | S-1/A (amendment) | OS Therapies Inc | 0001213900-25-000849 ↗ |
| 2025-01-13 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-25-000088 ↗ |
| 2025-01-31 | S-1 | S-1 (registration) | OS Therapies Inc | 0001213900-25-008855 ↗ |
| 2025-02-13 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-25-000446 ↗ |
| 2025-04-23 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-25-001200 ↗ |
| 2025-04-23 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-25-001202 ↗ |
| 2025-05-23 | S-1 | S-1 (registration) | OS Therapies Inc | 0001213900-25-047395 ↗ |
| 2025-06-06 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-25-001863 ↗ |
| 2025-08-04 | S-1 | S-1 (registration) | OS Therapies Inc | 0001213900-25-071368 ↗ |
| 2025-08-12 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-25-002586 ↗ |
| 2025-08-25 | EFFECT | EFFECT (declared effective) | OS Therapies Inc | 9999999995-25-002736 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Acevedo Christopher P. | Officer | Chief Financial Officer | 4 | 2024–2026 | |
| Borg Joacim | Director | 1 | 2024 | ||
| Ciccio John | Director | 5 | 2024–2026 | ||
| GODDARD COLIN | Director | 2 | 2024–2025 | ||
| PETIT ROBERT | Officer | See Remarks | 3 | 2024–2026 | |
| Romness Paul A. | Director,Officer; Director,Officer,TenPercentOwner | President and CEO | 7 | 2024–2026 | |
| Search Theodore F. | Director | 5 | 2024–2026 | ||
| Jarry Olivier Roger | Director | 4 | 2024–2026 | ||
| McKean-Dieser Avril Suzette | Director | 4 | 2024–2026 | ||
| Auerbach Shalom | Other; TenPercentOwner | 9 | 2025 | ||
| Einodmil LLC | Other; TenPercentOwner | 9 | 2025 | ||
| Galzahr Karim | Director | 3 | 2025–2026 | ||
| EAGLE CRAIG | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-08-25 | OS Therapies Inc | Biotechnology | $10,000,000 | $5,000,000 | 10 | 1 |
| 2026-07-16 | OS Therapies Inc | Biotechnology | $9,250,000 | $1,600,000 | 1 | 1 |
| 2026-03-06 | OS Therapies Inc | Biotechnology | $2,000,000 | $2,000,000 | 9 | 1 |
| 2026-01-20 | OS Therapies Inc | Biotechnology | $7,531,884 | $3,498,650 | 9 | 1 |
| 2025-09-10 | OS Therapies Inc | Biotechnology | $3,777,808 | $3,777,808 | 10 | 1 |
| 2025-07-16 | OS Therapies Inc | Biotechnology | $4,216,794 | $4,216,794 | 27 | 1 |
| 2025-01-22 | OS Therapies Inc | Pharmaceuticals | $10,000,000 | $7,103,000 | 34 | 1 |
| 2023-12-14 | OS Therapies Inc | Biotechnology | $2,000,000 | $700,000 | 3 | 1 |
| 2023-01-11 | OS THERAPIES Inc | Other Health Care | $2,000,000 | $2,000,000 | 11 | 1 |
| 2021-09-01 | OS THERAPIES Inc | Other Health Care | $5,000,000 | $1,000,000 | 1 | 1 |
| 2020-05-01 | OS THERAPIES Inc | Other Health Care | $5,000,000 | $0 | 0 | 1 |
| 2019-12-05 | OS THERAPIES Inc | Other Health Care | $500,000 | $359,000 | 11 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.